Robin Shane Readnour - 24 Mar 2022 Form 3 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Robin Shane Readnour
Issuer symbol
ANTX
Transactions as of
24 Mar 2022
Net transactions value
$0
Form type
3
Filing time
24 Mar 2022, 21:21:08 UTC
Next filing
31 Mar 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ANTX Series A Convertible Preferred Stock 24 Mar 2022 Common Stock 285,156 See footnotes F1, F2, F4
holding ANTX Series A Convertible Preferred Stock 24 Mar 2022 Common Stock 333,135 See footnotes F1, F3, F4
holding ANTX Series B Convertible Preferred Stock 24 Mar 2022 Common Stock 61,491 See footnotes F1, F2, F4
holding ANTX Series B Convertible Preferred Stock 24 Mar 2022 Common Stock 71,839 See footnotes F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
F2 Shares held directly by MGC Venture Partners 2018, LP. ("MGC 2018 LP").
F3 Shares held directly by MGC Venture Partners QP 2018 LP ("MGC 2018 QP").
F4 MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP. MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.

Remarks:

Exhibit 24 - Power of Attorney